Key result
Continuous intracoronary adenosine was noninferior to intravenous adenosine for measuring mean hyperaemic FFR.
Why the study?
To evaluate the accuracy of continuous intracoronary adenosine infusion administered via a novel over-the-wire microcatheter compared with intravenous infusion for fractional flow reserve measurement.
Does continuous intracoronary adenosine provide non-inferior fractional flow reserve assessment compared to standard intravenous adenosine in patients with intermediate coronary lesions?
RCT (n=41)
Single-blind
Randomised crossover
Yes
Does continuous intracoronary adenosine provide non-inferior fractional flow reserve assessment compared to standard intravenous adenosine in patients with intermediate coronary lesions?
Answers are grounded in this paper and cite their sources.
Continuous intracoronary adenosine via a novel microcatheter is non-inferior to standard intravenous adenosine for FFR measurement, while achieving maximal hyperaemia faster and causing less chest discomfort.
AIMS: The aim of this study was to evaluate the accuracy of a continuous intracoronary (IC) adenosine infusion, administered through the novel HYPEREM™IC over-the-wire microcatheter, to measure fractional flow reserve (FFR). METHODS AND RESULTS: The HYPEREMIC trial was a randomised, non-inferiority, crossover study in which patients with intermediate coronary lesions were enrolled for sequential pressure wire studies. FFR was measured using intravenous (IV) (140-180 mcg/kg/min) versus continuous non-weight-adjusted IC (360 mcg/min) adenosine. Patients were randomised and blinded to the order in which they received the adenosine, separated by a washout period. The primary endpoint was the mean hyperaemic FFR. Forty-one patients were enrolled at three UK sites between June and November 2016. The mean (standard deviation) FFR was 0.82 (±0.09) after IC versus 0.84 (±0.09) after IV adenosine. The difference of -0.02 (95% confidence interval [CI]: -0.03 to -0.01) confirmed the non-inferiority (margin <0.05) of IC to IV adenosine. Intracoronary adenosine was associated with a shorter mean time to maximal hyperaemia (difference -44 [95% CI: -59 to -29] seconds; p<0.0001). Chest discomfort was reported in 32/41 (78.0%) patients during IV adenosine versus 12/41 (29.3%) patients during IC adenosine. CONCLUSIONS: Continuous IC adenosine was a reliable, faster and better tolerated method of achieving maximal hyperaemia compared to IV adenosine.
No takes yet. Share an insight, caveat, or question.
Elghamaz et al. (2020) conducted an RCT in Intermediate coronary lesions (n=41). Continuous intracoronary (IC) adenosine vs. Intravenous (IV) adenosine (140-180 mcg/kg/min) was evaluated on Mean hyperaemic FFR (MD -0.02, 95% CI -0.03 to -0.01). Continuous intracoronary adenosine was noninferior to intravenous adenosine for measuring mean hyperaemic FFR.
Synapse has enriched 10 related papers. Consider them for comparative context: